A hair removal study with Ellipse I²PL involving 365 patients shows that 3-7 treatments result in a clearance rate averaging 96%. Acne and facial telangiectasias studies show similar impressing results. See abstracts
“We are very pleased to announce that 2011 was another strong year for Ellipse with overall revenue growth of 10% and doubling of net result compared to the previous year said Jacob Kildegaard Larsen, CEO of Ellipse.
Ellipse A/S is according to a new survey from Greens among Denmark's 500 most successful companies in terms of growth in gross results from 2008 to 2010.
MultiFlex+ combines an innovative Nd:YAG and the PLUS series of I²PL applicators to allow a wide range of dermatologic treatments such as leg veins, facial telangiectasias, reticular vessels, resistant port wine stains and venous lakes.
